Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization
This article was originally published in The Tan Sheet
Executive Summary
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.